Pharma-Bio Serv, Inc.
PBSV
$0.60
-$0.09-13.03%
OTC PK
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 33.93% | 144.62% | 103.14% | 134.18% | -158.76% |
| Total Depreciation and Amortization | 31.31% | 36.02% | 11.40% | 3.56% | -7.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -28.25% | 522.52% | 24.07% | 127.30% | -193.47% |
| Change in Net Operating Assets | 231.74% | 3.04% | -132.35% | -105.04% | -186.33% |
| Cash from Operations | 135.28% | 56.96% | -159.17% | -74.58% | -170.06% |
| Capital Expenditure | -5.26% | -- | -- | -9,912.50% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -55.83% | -602.24% | 120.75% | -95.52% | 159.78% |
| Cash from Investing | -55.86% | -603.16% | 120.75% | -97.66% | 159.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -194.12% | -647.83% | -- | 100.00% | 66.67% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 0.13% | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -194.12% | -0.73% | -- | 100.00% | 66.67% |
| Foreign Exchange rate Adjustments | 161.97% | 358.79% | -257.85% | 95.19% | -184.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -38.07% | -79.54% | 113.39% | -96.74% | 157.60% |